MILANO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 543
EU - Europa 391
AS - Asia 201
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 1.139
Nazione #
US - Stati Uniti d'America 543
IE - Irlanda 156
IT - Italia 144
HK - Hong Kong 62
VN - Vietnam 47
CN - Cina 41
SG - Singapore 34
RU - Federazione Russa 19
FR - Francia 14
SE - Svezia 12
UA - Ucraina 10
FI - Finlandia 9
KR - Corea 9
TR - Turchia 7
DE - Germania 5
AT - Austria 4
GB - Regno Unito 4
PL - Polonia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EU - Europa 3
BE - Belgio 2
GR - Grecia 2
CI - Costa d'Avorio 1
UZ - Uzbekistan 1
Totale 1.139
Città #
Dublin 156
Chandler 135
San Mateo 74
Hong Kong 62
Perugia 58
Dong Ket 47
Medford 29
Princeton 27
Lawrence 26
Pisa 26
Singapore 22
Redmond 17
Wilmington 17
Altamura 16
Des Moines 15
Andover 14
Beijing 14
Rome 11
Boardman 10
Seoul 9
Saint Petersburg 8
San Paolo di Civitate 8
Izmir 7
Helsinki 6
Florence 5
Norwalk 5
Los Angeles 3
Olomouc 3
Vienna 3
Brussels 2
Gradara 2
Munich 2
New York 2
Padova 2
Redwood City 2
Abidjan 1
Acireale 1
Ann Arbor 1
Ashburn 1
Civitanova Marche 1
Dearborn 1
Foligno 1
Frankfurt Am Main 1
Fremont 1
Kiev 1
Moscow 1
San Diego 1
Shanghai 1
Todi 1
Woodbridge 1
Totale 860
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 117
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 103
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 78
Mutant NPM1 Maintains the Leukemic State through HOX Expression 63
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 52
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 48
Low level of Her-2 locus amplification by fluorescent in situ hybridization does not correlate with Her-2 protein overexpression by immunohistochemistry in Barrett's esophagus 44
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 43
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 42
Bone Morphogenetic Protein 4 Expressed in Esophagitis Induces a Columnar Phenotype in Esophageal Squamous Cells 40
An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes 40
Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens 39
Cytokeratin and CDX-2 expression in Barrett's esophagus 39
Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery 37
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients 35
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 34
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer 33
A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia 33
Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia 32
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus 29
Expression pattern of immune suppressive cytokines and growth factors in oesophageal adenocarcinoma reveal a tumour immune escape-promoting microenvironment 29
Electroporation of dendritic cells with autologous total RNA from tumor material 28
Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population 27
Gene expression profile comparison of Barrett's esophagus epithelial cell cultures and biopsies 26
A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia 25
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 23
Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response 22
Current status and future perspectives in targeted therapy of NPM1-mutated AML 21
Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine 20
Novel therapeutic strategies for treating esophageal adenocarcinoma: The potential of dendritic cell immunotherapy and combinatorial regimens 17
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations 14
Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model 5
Totale 1.238
Categoria #
all - tutte 5.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 2 0 1 0 6 1 0 2 1 11 5 0
2020/2021191 0 0 0 0 86 3 0 19 31 2 0 50
2021/2022241 11 55 1 3 8 0 1 68 3 7 46 38
2022/2023492 27 78 13 19 54 62 1 17 191 6 18 6
2023/2024195 7 23 9 6 3 0 63 0 4 8 34 38
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 1.238